M
Michael S. Rohr
Researcher at Wake Forest University
Publications - 33
Citations - 1480
Michael S. Rohr is an academic researcher from Wake Forest University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 17, co-authored 33 publications receiving 1442 citations. Previous affiliations of Michael S. Rohr include Wake Forest Baptist Medical Center.
Papers
More filters
Journal Article
Complications from permanent hemodialysis vascular access.
Gazi B. Zibari,Michael S. Rohr,M. D. Landreneau,R. M. Bridges,G. A. Devault,F. H. Petty,K. J. Costley,S. T. Brown,John C. McDonald +8 more
TL;DR: Use of PTFE to construct permanent hemodialysis vascular access has a significantly higher incidence of thrombosis, infection, pseudoaneurysm formation, and limb loss and a significantly lower mean length of patency when compared with autogenous fistulas.
Journal ArticleDOI
Increased Kidney Transplantation Utilizing Expanded Criteria Deceased Organ Donors with Results Comparable to Standard Criteria Donor Transplant
Robert J. Stratta,Michael S. Rohr,Aimee K. Sundberg,Gregory T Armstrong,Gloria Hairston,Erica L. Hartmann,Alan C. Farney,Julie Roskopf,Samy S. Iskandar,Patricia L. Adams +9 more
TL;DR: The use of ECD kidneys at the authors' center effectively doubled their transplant volume within 1 year, and a systematic approach to E CD kidneys based on nephron mass matching and nephrons sparing measures may provide optimal utilization with short-term outcomes and renal function comparable to SCD kidneys.
Journal ArticleDOI
Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality?
Robert J. Stratta,Michael S. Rohr,Aimee K. Sundberg,Alan C. Farney,Erica L. Hartmann,Phillip S. Moore,Jeffrey Rogers,Samy S. Iskandar,Michael D. Gautreaux,David F. Kiger,William Doares,Teresa K. Anderson,Gloria Hairston,Patricia L. Adams +13 more
TL;DR: By appropriate donor and recipient profiling and the use of management algorithms to project and protect renal function, excellent intermediate-term outcomes can be achieved with ECD kidneys transplants that are comparable to SCD kidney transplants.
Journal Article
Effects of tacrolimus on hyperlipidemia after successful renal transplantation
Thomas R. McCune,Leroy R. Thacker,Thomas Peters,Laura L. Mulloy,Michael S. Rohr,Patricia A. Adams,Jackson Joe Yium,Jimmy A. Light,Timothy L. Pruett,A. O. Gaber,Steven H. Selman,Johann Jonsson,Joseph M. Hayes,Francis H. Wright,Thomas Armata,Jack Blanton,James F. Burdick +16 more
TL;DR: Tacrolimus has been shown to have less adverse effect on the lipid profiles of transplant patients when the drug is started as induction therapy as mentioned in this paper, and conversion from cyclosporine-treated renal transplant patients with established hyperlipidemia can be safely done after successful transplantation.
Journal ArticleDOI
Opportunistic Infections with Strongyloides stercoralis in Renal Transplantation
George A. DeVault,John W. King,Michael S. Rohr,Michael D. Landreneau,Stephen T. Brown,John C. McDonald +5 more
TL;DR: Prophylactic monthly administration of thiabendazole in immunocompromised patients who have survived strongyloides hyperinfection or dissemination can prevent reinfection.